Porvair plc (LON:PRV - Get Free Report) insider Hooman Caman Javvi bought 5,946 shares of the business's stock in a transaction dated Monday, October 26th. The shares were acquired at an average cost of GBX 833 per share, for a total transaction of £49,530.18.
Hooman Caman Javvi also recently made the following trade(s):
- On Thursday, October 15th, Hooman Caman Javvi bought 5,567 shares of Porvair stock. The stock was bought at an average cost of GBX 890 per share, for a total transaction of £49,546.30.
Porvair Stock Up 0.2%
PRV opened at GBX 831.68 on Tuesday. The business's 50-day simple moving average is GBX 868.43 and its 200-day simple moving average is GBX 818.51. The company has a debt-to-equity ratio of 14.49, a quick ratio of 1.22 and a current ratio of 1.94. Porvair plc has a one year low of GBX 678.82 and a one year high of GBX 938. The stock has a market capitalization of £384.28 million, a P/E ratio of 20.59 and a beta of 0.52.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on PRV. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 1,050 price target on shares of Porvair in a report on Thursday, October 15th. Berenberg Bank decreased their price objective on shares of Porvair from GBX 1,050 to GBX 1,000 and set a "buy" rating on the stock in a report on Thursday, October 15th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Porvair has an average rating of "Moderate Buy" and an average price target of GBX 1,025.
Get Our Latest Analysis on PRV
About Porvair
(
Get Free Report)
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Porvair, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Porvair wasn't on the list.
While Porvair currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.